2023 News Release

The 17th Survey on Sei-katsu-sha Attitudes Toward Drugs and the Pharmaceutical Industry" is now available.

Joint statement by the three pharmaceutical organizations of Japan, the U.S. and Europe:
Joint Statement on Reform of the NHI Drug Price System and Cost-Effectiveness Evaluation System in FY2024

Educational Event in the Pharmaceutical and Medical Fields "Living with Disease. Living with Hope. Photograph exhibition "Living with Disease, Living with Hope: Unseen Answers for the Future

JPMA Code of Practice "Code Understanding Promotion Month

JPMA "Open Call for Researcher Support and Subsidies

JPMA "Proposal on Intractable and Rare Diseases

Joint statement by the three JPMA organizations on the "Draft Report of the Expert Panel on Comprehensive Measures to Achieve a Rapid and Stable Supply of Pharmaceuticals"

JPMA Chairman's Press Conference held on May 25, 2011

Election of New Board Members

Review of the classification of novel coronaviruses under the Infectious Diseases Control Law

Public awareness booklet on the use of health and medical data
Publication of "Health and Medical Data and Our Lives

Research and Recommendations on the Contribution of the Pharmaceutical Industry to Extending Healthy Life Expectancy and Driving Economic Growth: Toward the Future of the Pharmaceutical Industry

On the occasion of the 12th Asian Pharmaceutical Consortium Meeting

The 12th APAC (Asia-Pacific Association of Pharmaceutical Manufacturers and Associations) Press Conference held on April 19

Joint statement by the three pharmaceutical organizations of Japan, the U.S., and Europe:
Proposals for the 2024 NHI Drug Price Reform

JPMA Policy Proposal 2023

JPMA Chairman's Press Conference held on February 16

JPMA "Survey on the problems of patients with rare diseases

JPMA President's New Year's Greetings 2023